Hemoperfusion in Critical Patients With Septic Multiorgan Dysfunction Syndrome.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorHospital Clinic of Barcelona

About this trial

Low-level interventional clinical trial to evaluate the effectiveness and safety of extracorporeal support with hemoperfusion in critical patients with septic multiorgan dysfunction syndrome.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Sepsis of abdominal origin with controlled infectious focus.

Noradrenaline dose> 0.5 µg / kg / min to maintain adequate organ perfusion after optimization of fluid therapy.

Dysfunction of two or more organs with SOFA ≥ 9 (5).

Blood lactate ≥ 2 mmol / L.

Disqualifiers

Age under 18 years or over 80 years.

Pregnancy or breastfeeding.

Terminally ill patients or with a life expectancy of less than 48 hours.

Thrombocytopenia <60,000 / mm3.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Extracorporeal support with haemoperfusion

    Procedure/Surgery

    Use of extracorporeal support with haemoperfusion

  • Conventional treatment

    Procedure/Surgery

    Conventional treatment

Treatment groups

48 Participants
are divided into 2 treatment groups
Group A: Conventional treatmentActive comparator 1 intervention
Group B: Extracorporeal support with haemoperfusion treatmentExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

IL-6 plasmatic concentration

Analyze the patient's variation of IL-6 plasmatic concentration during the hemoperfusion process

Time frame
During hemoperfusion
2

Adverse events

Analyze the presence of adverse events during the hemoperfusion process

Time frame
During hemoperfusion
3

Organ failure

Analyze the number and severity of failed organs during the hemoperfusion process

Time frame
During hemoperfusion
4

Vasopressors dose

Analyze the patient's vasopressor dose variation during the hemoperfusion process

Time frame
During hemoperfusion

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hospital Clinic of Barcelona

Lead sponsor

Hospital General Universitario de Castellón

Collaborator

Hospital Universitario La Paz

Collaborator

Hospital de Granollers

Collaborator

Hospital General Universitario Santa Lucía

Collaborator